Dr. J. Louis Hinshaw on Tumor Ablation, Histotripsy, and the Future of Interventional Oncology

Repeatable, organ-sparing care: Minimally invasive ablation lets clinicians control metastatic disease across years with quick recovery. Histotripsy is promising (and young): Early clinical use shows a favorable safety p...more